• Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Источник: Buzz FX / 15 мар 2025 08:52:17   America/Chicago


    Allogene Therapeutics, Inc. (NASDAQ:ALLO) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Shares of Allogene Therapeutics, Inc.
    Read more...
Опубликовать